Head-to-head · WeighScore
Coivas vs Dr. Arevitalize
The verdict
Coivas takes it — 66.2/100 to 65.2/100, but only just.
Coivas grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC. Dr. Arevitalize is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Coivas | Dr. Arevitalize |
|---|---|---|
| WeighScore | 66.2/100 | 65.2/100 |
| Grade | C | C |
| Scorecard rank | #194 | #225 |
| Semaglutide | $149/mo (quarterly plan, compounded) | $319/mo (compounded) |
| Tirzepatide | $229/mo (quarterly plan, compounded) | $359/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #194 · C
Strengths
- All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
- Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
- Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
- Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
- Most patients approved in under 2 hours; refund if no provider visit or prescription occurs
Where it loses points
- Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
- Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
- Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
- No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
Graded #225 · C
Strengths
- Offers both injectable and oral-capsule compounded GLP-1 — a needle-free option many providers do not carry
- Semaglutide from $269/mo and tirzepatide from $349/mo, in 1-, 3-, 6-, and 12-month bundles
- LegitScript-certified; clinician-guided with lab/bloodwork analysis and personalized plans
- Intro pricing on injectable semaglutide ($269, was $319) and oral semaglutide ($299, was $349)
Where it loses points
- Compounded GLP-1s are not FDA-approved finished products
- Compounding pharmacy partner and prescribing clinician are not named on the site
- State availability is not published on the site
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.